ArticleFrontiers in immunology2026

Not all major pathological responses are equal: prognostic heterogeneity and risk stratification after neoadjuvant chemoimmunotherapy in resectable NSCLC.

Jiong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.